REVB Revelation Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q May 7, 2026REVB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
REVB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Jan. 28, 2026 | 1-for-4 | Reverse |
| July 7, 2025 | 1-for-3 | Reverse |
| Jan. 28, 2025 | 1-for-16 | Reverse |
| Jan. 25, 2024 | 1-for-30 | Reverse |
| Feb. 1, 2023 | 1-for-35 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | REVB | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.2 | · | 0.6 | Undervalued |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | REVB | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 10.0 | · | 2.2 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $-0.87 | $-0.85 | -2.8% |
| March 31, 2026 | May 6, 2026 | $-2.71 | $-1.17 | -131.0% |
| Dec. 31, 2025 | $-23.95 | $-3.73 | -541.5% | |
| Sept. 30, 2025 | $-7.08 | $-5.45 | -30.0% | |
| June 30, 2025 | $-28.04 | $-18.18 | -54.3% | |
| March 31, 2025 | $-25.32 | $-84.21 | 69.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q1 2026 | Q2 2024 |
|---|---|---|---|
| R&D Expense | $1M | $1M | |
| SG&A Expense | $2M | $1M | |
| Operating Expenses | $3M | $3M | |
| Operating Income | $-3M | $-3M | |
| Other Non-op | $83.4K | $-6M | |
| Income Tax | · | $0 | |
| Net Income | $-3M | $-8M | |
| EPS (Basic) | $-2.71 | $-5.13 | |
| EPS (Diluted) | $-2.71 | $-5.13 | |
| Shares (Basic) | 3,207,720 | 1,635,234 | |
| Shares (Diluted) | 3,207,720 | 1,635,234 | |
| EBITDA | $-3M | $-3M |
Balance Sheet
| Metric | Trend | Q1 2026 | Q2 2024 |
|---|---|---|---|
| Cash & Equivalents | $14M | $12M | |
| Prepaid Expense | $92.6K | $125.7K | |
| Current Assets | $14M | $12M | |
| PP&E (Net) | $140.7K | $70.8K | |
| PP&E (Gross) | $246.9K | $151.1K | |
| Accum. Depreciation | $106.2K | $80.4K | |
| Other Non-current Assets | $30.9K | · | |
| Total Assets | $15M | $12M | |
| Accounts Payable | $828.2K | $1M | |
| Accrued Liabilities | $468.1K | $8M | |
| Current Liabilities | $1M | $11M | |
| Capital Leases | $638.2K | · | |
| Total Liabilities | $2M | $11M | |
| Common Stock | $3.9K | $1.6K | |
| Paid-in Capital | $65M | $38M | |
| Retained Earnings | $-52M | $-37M | |
| Stockholders' Equity | $13M | $1M | |
| Liabilities + Equity | $15M | $12M | |
| Shares Outstanding | 3,908,420 | 1,643,395 |
Cash Flow
| Metric | Trend | Q1 2026 | Q2 2024 |
|---|---|---|---|
| Stock-based Comp | $471.0K | · | |
| Operating Cash Flow | $-3M | · | |
| CapEx | $71.9K | · | |
| Investing Cash Flow | $-71.9K | · | |
| Financing Cash Flow | $7M | · | |
| Free Cash Flow | $-3M | · |
Profitability
| Metric | Trend | Q1 2026 | Q2 2024 |
|---|---|---|---|
| ROA | -31.6% | -59.3% | |
| ROE | -37.9% | -133.7% |
Liquidity & Solvency
| Metric | Trend | Q1 2026 | Q2 2024 |
|---|---|---|---|
| Current Ratio | 10.0 | 1.1 | |
| Quick Ratio | 10.0 | 1.1 |
Per Share
| Metric | Trend | Q1 2026 | Q2 2024 |
|---|---|---|---|
| Book Value / Share | $3.32 | $0.69 | |
| Cash Flow / Share | $-1.00 | · | |
| Cash / Share | $3.61 | $7.35 |
Valuation (TTM)
| Metric | Trend | Q1 2026 | Q2 2024 |
|---|---|---|---|
| Market Cap | $5M | $151M | |
| P/B | 0.4 | 132.1 | |
| P / Tangible Book | 0.4 | 132.1 | |
| P / Cash Flow | -1.5 | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 13 filers · $338K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 3 | 3 | 2 | 1 | · |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | $216,899 | 210,582 | 64.14% | Shares |
| VANGUARD GROUP INC | $42,004 | 52,505 | 12.42% | Shares |
| CITADEL ADVISORS LLC | $39,736 | 38,579 | 11.75% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $17,707 | 17,192 | 5.24% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $13,521 | 13,127 | 4.00% | Shares |
| Tower Research Capital LLC (TRC) | $6,724 | 6,528 | 1.99% | Shares |
| ROYAL BANK OF CANADA | $1,000 | 747 | 0.30% | Shares |
| SBI Securities Co., Ltd. | $354 | 344 | 0.10% | Shares |
| BARCLAYS PLC | $173 | 168 | 0.05% | Shares |
| HARBOUR INVESTMENTS, INC. | $42 | 41 | 0.01% | Shares |
| HRT FINANCIAL LP | $17 | 16,978 | 0.01% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $9 | 9 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | Shares |
Company insiders 9 insiders · 4 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| James Rolke | Chief Executive Officer | April 30, 2026 F | 214,738 | 0 | 0 | $0 |
| Sean H Fitzpatrick | Chief Executive Officer | Dec. 30, 2020 J | 1,769,538 | 0 | 0 | $0 |
| Andreas Typaldos | Chief Executive Officer | Dec. 30, 2020 J | 1,769,538 | 0 | 0 | $0 |
| Chester Stanley Zygmont III | Chief Financial Officer | April 30, 2026 F | 92,063 | 0 | 0 | $0 |
| Jennifer Carver | Director | Feb. 3, 2026 F | 12,758 | 0 | 0 | $0 |
| Lakhmir S Chawla | Director | Feb. 3, 2026 F | 12,158 | 0 | 0 | $0 |
| Jess Roper | Director | Feb. 3, 2026 F | 12,828 | 0 | 0 | $0 |
| George F Tidmarsh | Director | Feb. 11, 2025 A | 268 | 0 | 0 | $0 |
| Curt H Labelle | Director | April 14, 2023 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
REVB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
2 analysts · 2026-10-03Mean target $17.75 +2224.5%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| REVB | · | · | · | · | · | · |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | · |
| APVO | $9M | -0.1 | · | · | -217.2% | · |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| DCOY | · | -0.0 | · | · | · | · |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| ADTX | $343.6K | -0.0 | -97.6% | -1349028.2% | -1183.4% | 8.4% |
| SBFM | · | · | · | · | · | · |
| BCAB | · | -0.6 | · | · | · | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.